Robert McLeod, MD
Vice President Clinical Development
Robert joined Myricx in September 2023.
Robert is a senior pharmaceutical physician with over 20 years drug development experience gained while working in the US and Europe.
Most recently Robert was Senior Director Clinical Development, Global Oncology R&D at Daiichi Sankyo, Inc. based in New York, where he was responsible for early phase R&D for several antibody drug conjugates (ADCs) across multiple solid tumour indications.
Previously, he spent eight years at Cancer Research UK as Clinical Research Physician, in its Centre for Drug Development, focused on translational medicine and early phase oncology trials across a range of solid and haematological malignancies.
He has also held several industry roles in the UK and Germany at Emergent BioSolutions, Encysive Pharmaceuticals, Novartis, Chiron and Noxxon Pharma, after having trained and worked as a physician in both Australia and UK at the beginning of his career.
Robert gained his Degree in Medicine from the University of Melbourne, a Diploma in Pharmaceutical Medicine from The Royal College Faculty of Pharmaceutical Medicine, London, and an MBA from the ESCP Business School, Berlin.
